Simultaneous separation and determination of coenzyme Q10 and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 2, 2008, Pages 230-237

  Nageswara Rao, R ^a   Kumar Talluri, M V Narendra ^a   Shinde, Dhananjay D ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

APCI MS; Coenzyme Q10; Dietary supplement; Non aqueous reversed phase HPLC; Related substances

Indexed keywords

UBIDECARENONE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG ISOLATION; LIGHT EMITTING DIODE; MASS SPECTROMETRY; NON AQUEOUS REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ATMOSPHERIC PRESSURE; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; UBIQUINONE;

EID: 42749090646     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.12.034     Document Type: Article

References (25)

1. Palamakula A., and Khan M.A. Int. J. Pharm. 273 (2004) 63-73
2. Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee H.B., and Cho S.H. Int. J. Pharm. 274 (2004) 65-73
3. Turunen M., Olsson J., and Dallner G. Biochim. Biophys. Acta 1660 (2004) 171-199
4. Tarnopolsky M.A., and Beal M.F. Ann. Neurol. 49 (2001) 561-574
5. Hermann D.D. Am. J. Cardiovasc. Drugs 2 (2002) 173-196
6. Gaby A.R. Altern. Med. Rev. 1 (1996) 168-175
7. Roffe L., Schmidt K., and Ernst E. J. Clin. Oncol. 22 (2004) 4418-4424
8. Jones K., Hughes K., Mischley L., and McKenna D.J. Altern. Ther. Health Med. 10 (2004) 22-31
9. Bhagavan H.N., and Chopra R.K. Clin. Nutr. 24 (2005) 331-338
10. Beal M.F. Free Radic. Res. 36 (2002) 455-460
11. Sharma S., Kheradpezhou M., Shavali S., Refaey H.E., Eken J., Hagen C., and Ebadi M. Methods Enzymol. 382 (2004) 488-509
12. Muller T., Buttner T., Gholipour A.F., and Kuhn W. Neurosci. Lett. 341 (2003) 201-204
13. Lieberman A., Lyons K., Levine J., and Myerburg R. Parkinsonism Relat. Disord. 11 (2005) 81-84
14. Folkers K., and Wolaniuk A. Drugs Exp. Clin. Res. 11 (1985) 539-545
15. Guzman D.D. Chem. Market Rep. 268 (2005) 29-30
16. Buettner C., Phillips R.S., Davis R.B., Gardiner P., and Mittleman M.A. Am. J. Cardiol. 99 (2007) 661-666
17. Karpińska J., Mikołuć B., and Piotrowska-Jastrze{ogonek}bska J. J. Pharm. Biomed. Anal. 17 (1998) 1345-1350
18. Bunaciu A.A., Aboul-Enein H.Y., and Fleschin S. Prep. Biochem. Biotechnol. 37 (2007) 59-65
19. Karpińska J., Mikołuć B., Motkowski R., and Piotrowska-Jastrze{ogonek}bska J. J. Pharm. Biomed. Anal. 42 (2006) 232-236
20. Grossi G., Bargossi A.M., Fiorella P.L., and Battino S.P.M. J. Chromatogr. A 593 (1992) 217-226
21. Kommuru T.R., Khan M.A., Ashraf M., Kattenacker R., and Reddy I.K. J. Pharm. Biomed. Anal. 16 (1998) 1037-1040
22. Nageswara Rao R., Kumar Talluri M.V.N., Murali Krishna T.S.V.N., and Ravindranath K. J. Pharm. Biomed. Anal. 46 (2008) 310-315
23. Lísa M., Holčapek M., Řezanka T., and Kabátová N. J. Chromatogr. A 1146 (2007) 67-77
24. Yakushina L., and Taranova A. J. Pharm. Biomed. Anal. 13 (1995) 715-718
25. ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland, 2005, Q2A (R1).